Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-24 Sale | 2023-08-25 4:30 pm | Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer | 33,000 | $2.33 | $76,890 | 258,042 (Direct) | View |
| 2022-08-23 Sale | 2022-08-24 4:47 pm | Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer | 3,325 | $3.47 | $11,538 | 266,121 (Direct) | View |
| 2022-08-18 Sale | 2022-08-22 8:05 pm | Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer | 28,675 | $3.6966 | $105,999 | 269,446 (Direct) | View |
| 2021-08-18 Sale | 2021-08-20 5:52 pm | Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer | 33,000 | $16.88 | $557,023 | 298,121 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-02 Tax Withholding | 2024-02-06 4:42 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Alam Kamran CHIEF FINANCIAL OFFICER | 1,288 | $1.51 | 840,937 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:43 pm | N/A 2034-01-02 | Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer | 590,413 | $0 | 1,432,638 (Direct) | View |
| 2023-12-14 Option Award | 2023-12-18 4:50 pm | N/A 2033-12-14 | Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer | 187,582 | $0 | 187,582 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 4:12 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer | 6,230 | $0 | 291,042 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-06 9:12 pm | N/A 2033-02-02 | Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer | 205,975 | $0 | 472,096 (Direct) | View |
| 2022-04-06 Option Award | 2022-04-08 4:27 pm | N/A 2032-04-06 | Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-02-23 Option Award | 2022-02-25 4:18 pm | N/A 2032-02-23 | Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-01-19 Option Award | 2021-01-20 8:20 pm | N/A 2031-01-19 | Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer | 70,000 | $0 | 70,000 (Direct) | View |
| 2020-09-23 Option Award | 2020-09-25 5:08 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer | 331,121 | $0 | 331,121 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-10 5:05 pm | N/A 2030-02-06 | ROCKET PHARMACEUTICALS INC. | RCKT | Alam Kamran SVP - Finance & PFO | 28,000 | $0 | 28,000 (Direct) | View |
| 2019-11-04 Option Award | 2019-11-06 5:05 pm | N/A 2029-11-04 | ROCKET PHARMACEUTICALS INC. | RCKT | Alam Kamran SVP - Finance & PFO | 200,000 | $0 | 200,000 (Direct) | View |